Lv2
144 积分 2023-10-31 加入
Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects
9天前
已完结
Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects
14天前
已完结
Lipoprotein(a) and residual cardiovascular risks in Japanese patients with coronary artery disease who achieve guideline-recommended low-density lipoprotein cholesterol goals
1个月前
已完结
Implementing the commitments of the World Health Assembly kidney health resolution: a key opportunity to improve health for millions
1个月前
已关闭
Clinical Correlates of Ambulatory BP Monitoring among Patients with CKD
1个月前
已完结
Nocturnal Hypertension or Nondipping: Which Is Better Associated With the Cardiovascular Risk Profile?
1个月前
已完结
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
2个月前
已完结
Achievement rate of target blood pressure in patients with hypertension treated by hypertension specialists and non-specialists in a real-world setting
2个月前
已完结
Early onset of hypertension and increased relative risks of chronic kidney disease and mortality: two population-based cohort studies in United Kingdom and Hong Kong
2个月前
已完结
Hypertension management in patients with advanced chronic kidney disease with and without dialysis
2个月前
已完结
皖公网安备34019202002308
